iPF2α-III metabolism. First total synthesis of 2,3-dinor iPF2α-III, a primary β-oxidation metabolite
The first total stereospecific synthesis of a key iPF2α-III metabolite is accomplished.
Section snippets
Acknowledgements
We wish to acknowledge the NIH for support under Grants DK44730 (J.R.), HL54500 and HL62250 (G.A.F.), and the NSF for an AMX-360 NMR instrument (Grant CHE-90-13145).
References (26)
- et al.
Tetrahedron Lett.
(1996) - et al.
Tetrahedron Lett.
(1997) - et al.
J. Biol. Chem.
(1998) - et al.
Tetrahedron Lett.
(1998) - et al.
Anal. Biochem.
(1998) - et al.
J. Biol. Chem.
(1999) - et al.
J. Biol. Chem.
(1996) FEBS Lett.
(1998)- et al.
J. Biol. Chem.
(1999) - et al.
J. Biol. Chem.
(2000)
J. Biol. Chem.
(1990)
Tetrahedron Lett.
(1999)
Tetrahedron Lett.
(2001)
Cited by (5)
Oxidized derivatives of ω-3 fatty acids: Identification of IPF <inf>3α</inf>-VI in human urine
2006, Journal of Lipid ResearchTotal synthesis of isoprostanes: Discovery and quantitation in biological systems
2004, Chemistry and Physics of LipidsThe first total synthesis of iPF<inf>4α</inf>-VI and its deuterated analog
2002, Tetrahedron LettersExploration of ω-side chain addition strategies for the syntheses of isocarbacyclin and 15R-16-(m-tolyl)-17,18,19,20-tetranorisocarbacyclin
2006, Organic and Biomolecular ChemistryThe emergence of the cyclopentenone prostaglandins as important, biologically active compounds
2002, Journal of the Chemical Society. Perkin Transactions 1
Copyright © 2001 Elsevier Science Ltd. All rights reserved.